1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on 3/September/2015.
2. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF et al. (eds). SEER Cancer Statistics Review, 1975–2012, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2012/, based on November 2014 SEER data submission, posted to the SEER web site, April 2015, accessed on 1/November/2015.
3. Management of the adnexal mass;Curtin;Gynecol. Oncol.,1994
4. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS);Menon;Lancet Oncol.,2009
5. Collège National des Gynécologues Obstétriciens Français. Management of presumed benign ovarian tumours: updated French guidelines;Brun;Eur. J. Obstet. Gynecol. Reprod. Biol.,2014